Supervisor：Ministry of Education of the People's Republic of ChinaSponsor：Sichuan University Editor-in-chief：LUO Fengming Publishing period：
Monthly
ISSN：1002-0179CN：51-1356/R
目的
了解四川省干部人群幽門螺桿菌（Helicobacler pylori，Hp）感染現狀、對 Hp 感染的認知程度及健康指導需求，為 Hp 感染的防治提供參考。
方法
對 2009 年 1 月—2014 年 12 月在四川大學華西醫院健康管理中心進行體檢的四川省干部人群進行碳 14尿素呼氣試驗檢測，并對檢測結果進行分析。隨機抽取部分人群進行對Hp感染認知程度及健康指導需求的問卷調查。
結果
共納入受檢者 285 例，受檢人群的 Hp 總感染率為 43.5%。收集合格問卷 128 份，對什么是 Hp、Hp 感染的危害、Hp 的傳播途徑、Hp 感染的預防措施、體檢篩查 Hp 的意義 5 個問題的了解率分別為 21.1%、18.8%、16.4%、15.6%、12.5%；有上述 5 個方面健康指導需求的人數占比分別為 84.4%、85.2%、78.9%、86.7%、76.6%。
結論
四川省干部人群 Hp 感染率低于全國平均水平，但對 Hp 感染的認知程度低，迫切需要規范的健康指導。
Citation：黃燕, 徐袁, 曾莉, 唐懷蓉. 四川省干部人群幽門螺桿菌感染現狀及健康指導需求調查. West China Medical Journal, 2017, 32(5): 742-744. doi: 10.7507/1002-0179.201507150Copy
Copyright ? the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved
1.
?Qiu HB, Zhang LY, Keshari RP, et al. Relationship betweenH. Pylori infection and clinicopathological features and prognosis of gastric cancer. BMC Cancer, 2010, 17(10): 374.
2.
Magdalena C, Adrian G, Karolina R, et al.Helicobacter pylori vs coronary heart disease- searching for connections. World J Cardiol, 2015, 7(4): 187-203.
3.
Gasbarrini A, Franceschi F, Tartaglione R, et al. Regression of autoimmune thrombocytopenia after eradication ofHelicobacter pylori. Lancet, 1998, 352(9131): 878.
4.
De Bastiani R, Gabrielli M, Ubaldi E, et al. High prevalence of Cag-A positiveH. pylori strains in ischemic stroke: a primary care multicenter study. Helicobacter, 2008, 13(4): 274-277.
5.
Vilaichone RK, Mahachai V, Shiota S, et al. Extremely high prevalence ofHelicobacter pylori infection in Bhutan. World J Gastroenterol, 2013, 19(18): 2806-2810.
6.
Hunt RH, Xiao SD, Megraud F, et al.Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis, 2011, 20(3): 299-304.
7.
Tonkic A, Tonkic M, Lehours P, et al. Epidemiology and diagnosis ofHelicobacter pylori infection. Helicobacter, 2012, 17(1, SI): 1-8.
1. ?Qiu HB, Zhang LY, Keshari RP, et al. Relationship betweenH. Pylori infection and clinicopathological features and prognosis of gastric cancer. BMC Cancer, 2010, 17(10): 374.
2. Magdalena C, Adrian G, Karolina R, et al.Helicobacter pylori vs coronary heart disease- searching for connections. World J Cardiol, 2015, 7(4): 187-203.
3. Gasbarrini A, Franceschi F, Tartaglione R, et al. Regression of autoimmune thrombocytopenia after eradication ofHelicobacter pylori. Lancet, 1998, 352(9131): 878.
4. De Bastiani R, Gabrielli M, Ubaldi E, et al. High prevalence of Cag-A positiveH. pylori strains in ischemic stroke: a primary care multicenter study. Helicobacter, 2008, 13(4): 274-277.
5. Vilaichone RK, Mahachai V, Shiota S, et al. Extremely high prevalence ofHelicobacter pylori infection in Bhutan. World J Gastroenterol, 2013, 19(18): 2806-2810.
6. Hunt RH, Xiao SD, Megraud F, et al.Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis, 2011, 20(3): 299-304.
7. Tonkic A, Tonkic M, Lehours P, et al. Epidemiology and diagnosis ofHelicobacter pylori infection. Helicobacter, 2012, 17(1, SI): 1-8.
1/5
WeChat